Company Overview
Snapshot
Founded in December 2019 by Eran Eshed and Dr. Assaf Ben-Meir, Fairtility operates with 11–50 employees. The company has raised $18.5M across three funding rounds from three investors. In February 2024, Kreos Capital participated in a funding round.
Business overview
Fairtility is at the forefront of powering in vitro fertilization (IVF) through transparent artificial intelligence to enhance outcomes. The company's core technology, CHLOE (Cultivating Human Life through Optimal Embryos), is an AI-based decision support tool that offers clinicians comprehensive visibility into clinical and laboratory parameters to improve IVF success rates. Fairtility serves the digital healthcare market, focusing on fertility and women's health, with products like CHLOE EQ, CHLOE KPI, and CHLOE OQ, aiming to span the entire IVF journey from infertility cause assessment to transfer optimization.
Strategic signal
In April 2022, Fairtility's AI-trained embryo labeling technique was highlighted for boosting IVF success rates. This signals a significant advancement in fertility treatment, demonstrating the company's capability to leverage artificial intelligence for tangible improvements in clinical outcomes and potentially reducing the emotional, physical, and financial burden on prospective parents.
Log in to access full profile ›Company Intelligence Q&A
- What is Fairtility's primary focus?
- Fairtility focuses on powering in vitro fertilization (IVF) through transparent artificial intelligence to improve outcomes and reduce the number of IVF cycles needed for a live birth.
- Who founded Fairtility?
- Fairtility was co-founded by Eran Eshed and Dr. Assaf Ben-Meir in December 2019.
- What is CHLOE?
- CHLOE (Cultivating Human Life through Optimal Embryos) is Fairtility's transparent AI-based decision support tool designed to provide clinicians with complete visibility into clinical and laboratory parameters to help improve IVF outcomes.
- What was a key development for Fairtility in April 2022?
- In April 2022, an AI-trained embryo labeling technique developed by Fairtility was recognized for its ability to boost IVF success rates.